Taiwanese Pharmaceuticals & Biotech Potentially Undervalued Companies

Lotus Pharmaceutical

Market Cap: NT$51.6b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Maxigen Biotech

Market Cap: NT$3.6b

Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.

Vetnostrum Animal Health

Market Cap: NT$2.4b

Engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed.

Synbio Tech

Market Cap: NT$1.6b

Manufactures and sells human healthcare products and probiotics for animals.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.2b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Syngen BiotechLtd

Market Cap: NT$2.2b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.7b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$2.8b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

TTY Biopharm

Market Cap: NT$19.3b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

Prince Pharmaceutical

Market Cap: NT$1.0b

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.

Cenra

Market Cap: NT$6.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Allied Biotech

Market Cap: NT$2.7b

Engages in the manufacture and sale of carotenoids worldwide.

Bioray Biotech

Market Cap: NT$605.0m

Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.

Cenra

Market Cap: NT$5.2b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Nang Kuang Pharmaceutical

Market Cap: NT$3.2b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

Orient Pharma

Market Cap: NT$5.4b

Engages in the development of new drugs in Taiwan and internationally.

HeXun Biosciences

Market Cap: NT$2.2b

Engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.

Easywell Biomedicals

Market Cap: NT$3.7b

Develops, manufactures, and sells generic pharmaceutical ingredients and products in America, China, and Taiwan.

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

YungShin Global Holding

Market Cap: NT$14.8b

Through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics.

RBC Bioscience

Market Cap: NT$290.5m

Manufactures and sells reagents and devices for life science and molecular diagnosis.

Winston Medical Supply

Market Cap: NT$1.1b

Develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Sinphar PharmaceuticalLtd

Market Cap: NT$6.2b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Handa Pharmaceuticals

Market Cap: NT$12.4b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.